Angiotensin II-receptor blockers

Will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

In the past few years, angiotensin II-receptor blockers have become available and are being heavily marketed and increasingly used. In various ways they differ from angiotensin-converting enzyme inhibitors (ACEIs). Until outcome data are available, they should continue to be used primarily in patients who should receive an ACEI but cannot tolerate the drug because of cough.

Original languageEnglish (US)
JournalJournal of Human Hypertension
Volume14
Issue numberSUPPL. 1
StatePublished - 2000

Fingerprint

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Hypertension
Cough
Therapeutics
Pharmaceutical Preparations

Keywords

  • Angiotensin II
  • Angiotensin II-receptor blockers
  • Angiotensin-converting enzyme inhibitors

ASJC Scopus subject areas

  • Internal Medicine

Cite this

@article{d7bb846ddcd043118f56ab7521537e1b,
title = "Angiotensin II-receptor blockers: Will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?",
abstract = "In the past few years, angiotensin II-receptor blockers have become available and are being heavily marketed and increasingly used. In various ways they differ from angiotensin-converting enzyme inhibitors (ACEIs). Until outcome data are available, they should continue to be used primarily in patients who should receive an ACEI but cannot tolerate the drug because of cough.",
keywords = "Angiotensin II, Angiotensin II-receptor blockers, Angiotensin-converting enzyme inhibitors",
author = "Kaplan, {Norman M}",
year = "2000",
language = "English (US)",
volume = "14",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Angiotensin II-receptor blockers

T2 - Will they replace angiotensin-converting enzyme inhibitors in the treatment of hypertension?

AU - Kaplan, Norman M

PY - 2000

Y1 - 2000

N2 - In the past few years, angiotensin II-receptor blockers have become available and are being heavily marketed and increasingly used. In various ways they differ from angiotensin-converting enzyme inhibitors (ACEIs). Until outcome data are available, they should continue to be used primarily in patients who should receive an ACEI but cannot tolerate the drug because of cough.

AB - In the past few years, angiotensin II-receptor blockers have become available and are being heavily marketed and increasingly used. In various ways they differ from angiotensin-converting enzyme inhibitors (ACEIs). Until outcome data are available, they should continue to be used primarily in patients who should receive an ACEI but cannot tolerate the drug because of cough.

KW - Angiotensin II

KW - Angiotensin II-receptor blockers

KW - Angiotensin-converting enzyme inhibitors

UR - http://www.scopus.com/inward/record.url?scp=0034049929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034049929&partnerID=8YFLogxK

M3 - Article

VL - 14

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

SN - 0950-9240

IS - SUPPL. 1

ER -